Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer.
about
The ginsenoside 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol induces autophagy and apoptosis in human melanoma via AMPK/JNK phosphorylationTU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppressionProtopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer.Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice.Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalinAmerican ginseng significantly reduced the progression of high-fat-diet-enhanced colon carcinogenesis in Apc (Min/+) miceInhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota.Herbal medicines as adjuvants for cancer therapeutics.Beneficial effects of 20(S)-protopanaxadiol on antitumor activity and toxicity of cyclophosphamide in tumor-bearing mice.Determination of American ginseng saponins and their metabolites in human plasma, urine and feces samples by liquid chromatography coupled with quadrupole time-of-flight mass spectrometryPalmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines.Identification of potential anticancer compounds from Oplopanax horridus.Differential effects of ginsenoside metabolites on slowly activating delayed rectifier K(+) and KCNQ1 K(+) channel currents.General and Genetic Toxicology of Enzyme-Treated Ginseng Extract: Toxicology of Ginseng Rh2.Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extractRole of intestinal microbiome in American ginseng-mediated colon cancer protection in high fat diet-fed AOM/DSS mice.Ginseng Metabolites on Cancer Chemoprevention: An Angiogenesis Link?Immunostimulatory effect of fermented red ginseng in the mouse modelAmerican Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics.Determination of ginsenoside compound K in human plasma by liquid chromatography-tandem mass spectrometry of lithium adductsDaikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer.Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer.Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers.Probiotic Lactobacillus paracasei A221 improves the functionality and bioavailability of kaempferol-glucoside in kale by its glucosidase activity.Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer.Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cellsDeglycosylation of wogonoside enhances its anticancer potential
P2860
Q28542379-BC9BA739-3EF1-41B9-9096-8889BCAC4C86Q33654829-B7F84D1B-28D1-403E-85BB-CCAD13D88847Q35131299-65AFC47A-A8B8-4E81-8A0F-97B94DF25CDFQ35511894-5F8FBCCD-8FA9-424C-A7E4-25760C045F4AQ35785294-CB351080-B519-4C58-971A-8DCE096D72BDQ35863092-A681E8F0-9376-4F19-AC00-DB169E50F1B7Q36105337-E23005BA-ACA3-4C21-BFBE-42508A10761BQ36126384-D90AAA2E-C24C-4419-A822-CB3821E05303Q36154035-B8260350-259B-497C-8CFF-A094B0FA3578Q36603771-66D5C78E-B253-478E-9BCD-D1C19DA1803FQ36679816-86B87021-0808-4978-8F27-D659178551AEQ37032408-682EBED1-1703-4910-A6C8-BFA007D49A74Q37060599-555F7961-A1A8-459A-AB4F-6E651AE69280Q37283797-B5E7875D-FFF7-41F3-B4E6-5725C7FA5A54Q37298231-7621F31F-0038-4399-885A-04B839987460Q37303203-8B2FEA8C-4BCB-485A-8903-7288130F0DC1Q38624616-229EB8D7-84C5-40F4-946B-384543CE7D9EQ38700575-F479768F-5DFE-4736-B5C2-916CB7D3F0B6Q38968207-635A2AAE-CE9F-485F-B35B-7A54F1F5B43CQ39574717-A5DED4F7-AC27-460F-93C4-3464658FD385Q41952897-569E7A18-7AE5-4010-975C-2BDE4EEE9BAEQ47100364-44BB9242-8B0C-4E13-AB48-C4E73781AE32Q47138706-122E83EA-2050-4F39-BCE5-130A017A54C0Q49632028-BEAE11B8-8025-4E35-BC09-FC395521A894Q55297552-0A4C848B-A431-49A6-84DD-07253FB7902AQ55413580-13656395-91CD-4DB0-A732-C99D1DF4BCDEQ58595424-165D75A8-0718-443A-96C0-763FB4130F9AQ58773872-5C21DD12-31CD-4E69-ADDA-01A9CCECFB97
P2860
Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@en
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@nl
type
label
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@en
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@nl
prefLabel
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@en
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@nl
P2093
P2860
P356
P1476
Ginsenoside compound K, not Rb ...... es in human colorectal cancer.
@en
P2093
Chong-Zhi Wang
Chun-Su Yuan
Eugene B Chang
Guang-Jian Du
Marc Bissonnette
Mark W Musch
Tyler Calway
Xiao-Dong Wen
Zhiyu Zhang
Zhong Zhen
P2860
P304
P356
10.3892/IJO.2012.1399
P577
2012-03-12T00:00:00Z